Lexicon Prescribed drugs inventory hits 52-week low at $0.73 By Investing.com
In a difficult yr for Lexicon Prescribed drugs (NASDAQ:) Inc., the corporate's…
Catalyst Prescribed drugs chief compliance officer sells $286,703 in inventory By Investing.com
CORAL GABLES, FL—Brian Elsbernd, the Chief Compliance and Authorized Officer of Catalyst…
Corvus Prescribed drugs Proclaims New Information Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Most cancers By Investing.com
BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Prescribed drugs, Inc.…
Eton Prescribed drugs sees $79,814 inventory buy by Opaleye administration By Investing.com
In a current submitting with the Securities and Change Fee, Opaleye Administration…
Alnylam Prescription drugs’ SWOT evaluation: inventory poised for progress as ATTR-CM drug reveals promise By Investing.com
Alnylam Prescription drugs (NASDAQ:ALNY), a pacesetter in RNA interference (RNAi) therapeutics, has…
Foresee Prescribed drugs Proclaims Preliminary Outcomes from a Part 1 Scientific Trial, Highlighting Promising Security, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Choose By Investing.com
TAIPEI, Oct. 20, 2024 /PRNewswire/ -- Foresee Prescribed drugs (TPEx: 6576), ("Foresee")…
Rhythm Prescription drugs declares voting outcomes By Investing.com
Rhythm Prescription drugs, Inc. (NASDAQ:), a biopharmaceutical firm, reported the outcomes of…
Terns Prescribed drugs director buys $5 million in firm inventory By Investing.com
In a latest transaction, Hongbo Lu, a director at Terns Prescribed drugs,…
JMP Securities highlights Imcivree’s position in Rhythm Prescription drugs inventory outlook By Investing.com
On Tuesday, Rhythm Prescription drugs (NASDAQ:) inventory acquired a constructive evaluation from…
Terns Prescription drugs CFO sells $110,000 in firm inventory By Investing.com
Terns Prescription drugs, Inc. (NASDAQ:TERN) Chief Monetary Officer Mark J. Vignola not…
